Back to search

Democritus University of Thrace (DUTH)

Η αλληλεπίδραση των ενδογενών ρετροϊών και της μεταγωγικής οδού των ιντερφερονών με την υπομεθυλιωτική θεραπεία στα Μυελοδυσπλαστικά Σύνδρομα

Abstract

dc:description

Myelodysplastic syndromes (MDS) and acute myelogenous leukemia (AML) are characterized by abnormal patterns of DNA methylation, which contribute to the pathophysiology of the disease, resulting in abnormal epigenetic suppression and differentiation of hematopoietic stem cells (HSCs). Hypomethylating agents (HMAs), which reverse this epigenetic suppression, such as 5-azacitidine (AZA) and 5-aza-2'-deoxycytidine (DAC), remain the main treatment of choice for patients with high-risk MDS and AML. Nevertheless, the exact mechanism of action of HMAs remains unclear, while prognostic factors of response to HMAs are absent. Recent data on cancer cell lines suggest that reactivation of endogenous retroviral elements and subsequent induction of an endogenous cellular antiviral response may be the background of the anti-cancer activity of HMA.Using RNA sequencing (RNA-seq), a comparison of endogenous retroviral transcript levels in HSC isolated from the bone marrow of patients with MDS and chronic myelomonocytic leukemia II (CMML-II), before and after treatment with AZA, and HSCs derived from bone marrow from healthy donors and patients with AM was performed.In agreement with previous literature reports, it was found that AZA treatment increased the transcription of endogenous retroviral elements. However, this increase was not correlated with the clinical response to AZA treatment, as it was observed in both responders and non-responders patients. This observation was also confirmed by performing de novo transcript assembly, revealing that AZA-responsive endogenous retroviruses are not a determinant of the outcome of the HMA treatment. There was also observed a lack of induction of an antiviral response of interferons associated with the AZA response. In contrast, it has been found that the therapeutic expression and alternative splicing process of specific, developmentally regulated genes may be prognostic factors for the response of patients with MDS and CMML-II to AZA therapy. In conclusion, this doctoral thesis identifies the developmentally regulated transcriptional signatures of protein-coding and non-coding genes, rather than endogenous retroviral elements, as correlates of a favourable response of MDS and CMML-II patients to AZA treatment and offers novel candidates for further evaluation.

Degree

thesis:*
Grantor dc:publisher
Democritus University of Thrace (DUTH)
Year dc:date
2021

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Kordella, Chrysoula
  • Κορδελλά, Χρυσούλα

Subjects

dc:subject × 18

Rights

dc:rights
Statement dc:rights
  • BY_4_0
Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/49263

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Kordella, Chrysoula; Κορδελλά, Χρυσούλα. Η αλληλεπίδραση των ενδογενών ρετροϊών και της μεταγωγικής οδού των ιντερφερονών με την υπομεθυλιωτική θεραπεία στα Μυελοδυσπλαστικά Σύνδρομα. Democritus University of Thrace (DUTH), 2021. http://hdl.handle.net/10442/hedi/49263